Especially problematic in heterogeneous breast cancers, much of the problem was credited to a lack of scoring consensus amongst experts; some advocate selective use of hotspots in assessment of Ki67 while others favor taking average of the invasive front [20]. The gene discussed is MKI67; the disease is breast carcinoma.